Governance

Board and management

Meet our Board of Directors here

Meet our Management Team here

Shareholdings as of 31 December 2023

The following entities hold more than 5% of the share capital and the voting rights in ViroGates:

  • N. P. Louis-Hansen ApS (Niels Peter Louis-Hansen) holds 24,79% of the shares and 25.47% of the voting rights
  • Ginnerup Capital ApS (Kim Ginnerup) holds 10.63% of the shares and 10.92% of the voting rights
  • 4AM ApS (Lars Krogsgaard, Board member) holds 10.63% of the shares and 10.92% of the voting rights
  • Aetas Healthcare ApS (Thomas Gielsgaard Hargreave) holds 5.95% of the shares and 6.12% of the voting rights

Governance documents

Articles of association

Appendix 1 and 2 to Articles of association

Appendix 3 to Articles of association

Remuneration policy and guidelines for incentive pay

1000+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of four products:

suPARnostic POC+

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates